What is Nuvation Bio's product revenue — deferred revenue?

Nuvation Bio (NUVB) reported product revenue — deferred revenue of $100K in Q1 2026.

What does product revenue — deferred revenue mean?

This metric reflects the company's obligation to transfer goods or services to a customer for which the company has already received consideration or for which an amount of consideration is due. It represents deferred revenue or performance obligations that have not yet been satisfied under existing customer contracts. Monitoring this balance provides insight into future revenue recognition potential and the timing of performance obligations within the product segment.

Nuvation Bio NUVB Product Revenue — Deferred Revenue

Other product segments

License

$58.7M—

Research And Development Service Revenue

$18.4M+9,100%

Royalty Revenue

$300K—

Similar metrics at other companies

PTCTProduct — Deferred Revenue

$0—

SIGOther Deferred Revenue — Contract with Customer, Liability

$86.5M+6.9%

TNLOther revenue — Contract Liabilities

$1M0.0%

JOEOther Products Or Services — Deferred Revenue

$14.7M-3.9%

CNKOther Deferred Revenues — Deferred Revenue

$272.6M+5.7%

EXTROther Deferred Revenue — Deferred Revenue

$14.13M-30.6%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.25B+150%

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's product revenue — deferred revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's product revenue — deferred revenue?: Nuvation Bio (NUVB) reported product revenue — deferred revenue of $100K in Q1 2026.
What does product revenue — deferred revenue mean?: This metric reflects the company's obligation to transfer goods or services to a customer for which the company has already received consideration or for which an amount of consideration is due. It represents deferred revenue or performance obligations that have not yet been satisfied under existing customer contracts. Monitoring this balance provides insight into future revenue recognition potential and the timing of performance obligations within the product segment.